SCHEMBL20205474

SCHEMBL20205474

c1ccc2c(c1)ccc1oc3cc(-c4cc5oc6cc7c(cc6c5c5c4oc4ccccc45)oc4cc(-c5ccc6c(c5)oc5ccc8ccccc8c56)c5oc6ccccc6c5c47)ccc3c12

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 4/20 0.43
L3MBTL1 Q9Y468 3/20 0.43
ABCG2 Q9UNQ0 7/20 0.40
CYP1A1 P04798 3/20 0.40
CYP1A2 P05177 3/20 0.40
PAX8 Q06710 2/20 0.40
AHR P35869 2/20 0.40
FYN P06241 1/20 0.40
MAPK3 P27361 1/20 0.40
NPC1 O15118 2/20 0.37
RAB9A P51151 1/20 0.37
KDM4E B2RXH2 4/20 0.36
MAPT P10636 4/20 0.36
HPGD P15428 4/20 0.36
HSD17B10 Q99714 4/20 0.36
CASP7 P55210 2/20 0.36
CYP3A4 P08684 2/20 0.36
MEN1 O00255 1/20 0.36
ALPI P09923 1/20 0.36
GAA P10253 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20205476 0.89 ALOX5 (0.44) L3MBTL1AHRNPC1RAB9AKDM4E
SCHEMBL20205454 0.88 GPR84 (0.39) TDP1L3MBTL1ABCG2CYP1A1CYP1A2
SCHEMBL20205605 0.87 ALOX5 (0.39) TDP1L3MBTL1AHRNPC1RAB9A
SCHEMBL20205568 0.84 ALOX5 (0.41) TDP1L3MBTL1CYP1A2RAB9AKDM4E
SCHEMBL18472714 0.84 TDP1 (0.40) TDP1L3MBTL1ABCG2CYP1A1CYP1A2
SCHEMBL20205571 0.82 CDC14B (0.43) L3MBTL1ABCG2AHRNPC1RAB9A
SCHEMBL21019258 0.82 CYP1A1 (0.42) TDP1L3MBTL1ABCG2CYP1A1CYP1A2
SCHEMBL20205597 0.82 CDC14B (0.45) L3MBTL1ABCG2AHRNPC1RAB9A
SCHEMBL21019580 0.81 ABCG2 (0.42) TDP1L3MBTL1ABCG2CYP1A1CYP1A2
SCHEMBL19091434 0.81 TDP1 (0.34) TDP1L3MBTL1ABCG2CYP1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11453680-B2 Bisbenzofuran-fused indeno[1,2-B]fluorene derivatives and related compounds as materials for organic electroluminescent devices (OLED) MERCK PATENT GMBH (DE) 2022-09-27 US disclosed
EP-3544985-B1 BISBENZOFURAN-FUSED INDENO[1,2-B]FLUORENE DERIVATIVES AND RELATED COMPOUNDS AS MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES (OLED) MERCK PATENT GMBH (DE) 2021-05-12 EP disclosed
WO-2018095940-A1 BISBENZOFURAN-FUSED INDENO[1,2-B]FLUORENE DERIVATIVES AND RELATED COMPOUNDS AS MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES (OLED) MERCK PATENT GMBH (DE) 2018-05-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11453680-B2 Bisbenzofuran-fused indeno[1,2-B]fluorene derivatives and related compounds as materials for organic electroluminescent devices (OLED) OCIAD2, OCIAD1, JUND TDP1 1461/4885L3MBTL1 1006/4885ABCG2 1560/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.